We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $37.3B
1-Year Est. Return 12.6%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$17.2B
AUM Growth
+$1.66B
Cap. Flow
+$584M
Cap. Flow %
3.4%
Top 10 Hldgs %
78.01%
Holding
63
New
4
Increased
16
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$180M
2
VIRT icon
Virtu Financial
VIRT
+$135M
3
TCOM icon
Trip.com Group
TCOM
+$106M
4
MA icon
Mastercard
MA
+$86.8M
5
CHRS icon
Coherus Oncology
CHRS
+$86.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 41.74%
2 Industrials 21.19%
3 Healthcare 14.6%
4 Financials 7.52%
5 Materials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$281B
$6.13B 35.69%
35,495,289
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
$3.47B 20.18%
65,031,667
GILD icon
3
Gilead Sciences
GILD
$187B
$901M 5.25%
11,125,816
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
$764M 4.45%
17,336,588
-3,836,722
-18% -$177M
UNVR
5
DELISTED
Univar Solutions Inc.
UNVR
$410M 2.39%
14,171,599
TCOM icon
6
Trip.com Group
TCOM
$25.8B
$383M 2.23%
7,256,928
+1,959,723
+37% +$106M
V icon
7
Visa
V
$700B
$347M 2.02%
3,292,775
+1,770,488
+116% +$180M
PYPL icon
8
PayPal
PYPL
$47B
$345M 2.01%
5,387,963
VIRT icon
9
Virtu Financial
VIRT
$5.69B
$329M 1.92%
20,330,503
+8,012,821
+65% +$135M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$12.9B
$323M 1.88%
3,472,712
TMO icon
11
Thermo Fisher Scientific
TMO
$227B
$284M 1.66%
1,503,087
JD icon
12
JD.com
JD
$38.2B
$279M 1.63%
7,306,572
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$264M 1.54%
4,883,568
TRQ
14
DELISTED
Turquoise Hill Resources Ltd
TRQ
$227M 1.32%
7,321,388
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
$211M 1.23%
1,505,325
+52,403
+4% +$7.12M
AR icon
16
Antero Resources
AR
$12.1B
$194M 1.13%
9,755,618
PPG icon
17
PPG Industries
PPG
$25B
$188M 1.09%
1,727,645
NFX
18
DELISTED
Newfield Exploration
NFX
$188M 1.09%
6,326,046
RDS.B
19
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$179M 1.04%
2,868,867
+418,919
+17% +$24M
ZTO icon
20
ZTO Express
ZTO
$15.9B
$171M 1%
12,176,750
GRA
21
DELISTED
W.R. Grace & Co.
GRA
$158M 0.92%
2,187,501
MA icon
22
Mastercard
MA
$507B
$130M 0.76%
923,068
+656,062
+246% +$86.8M
AMZN icon
23
Amazon
AMZN
$2.79T
$127M 0.74%
2,634,700
AVGO icon
24
Broadcom
AVGO
$1.7T
$91.2M 0.53%
3,760,500
CHRS icon
25
Coherus Oncology
CHRS
$219M
$87.5M 0.51%
+6,556,116
New +$86.7M

Similar funds

Temasek Holdings's Q3 2017 Portfolio in Review

As of Q3 2017, Temasek Holdings held 63 positions worth $17.2B, up 11% from $15.5B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Temasek Holdings deployed $584M of net new capital in Q3 2017, opening 4 new positions and adding to 16 existing holdings. Its largest new stake was Coherus Oncology: 6,556,116 shares worth $87.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, up from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was IHS Markit Ltd. Common Shares, an estimated $177M trimmed.

  • Temasek Holdings's largest Q3 2017 buy was Coherus Oncology: 6,556,116 shares worth $87.5M.
  • Temasek Holdings added most to Visa in Q3 2017, an estimated $180M increase.
  • Temasek Holdings's biggest Q3 2017 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $177M.
  • Temasek Holdings fully exited Link Motion Inc. in Q3 2017, selling an estimated $828K.
  • Temasek Holdings's ten largest holdings make up 78% of its $17.2B portfolio in Q3 2017.
  • Temasek Holdings opened 4 new positions and closed 2 in Q3 2017.
  • Temasek Holdings's portfolio value rose 11% quarter-over-quarter to $17.2B.

Based on Temasek Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.